Related references
Note: Only part of the references are listed.Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physicianreported spondylitis'?' by Braun and Landewe
Juergen Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewe
Dafna D. Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?
Juergen Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
HAVE TREATMENTS FOR AUTOIMMUNE DISEASES WORSENED THE PROGNOSIS OF COVID-19 INFECTION?
A. I. Rebollo Gimenez et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study
Fabian Proft et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
Laura C. Coates et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study
Nelly Ziade et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)
Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
Xabier Michelena et al.
RMD OPEN (2022)
Peripheral spondyloarthritis and psoriatic arthritis sine psoriase: are we dealing with semantics or clinically meaningful differences?
Nelly Ziade et al.
RMD OPEN (2022)
Efficacy and safety of guselkumab in biologic-naive patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial
Dafna D. Gladman et al.
TRIALS (2022)
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial
Fabian Proft et al.
BMJ OPEN (2021)
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Philip J Mease et al.
Lancet Rheumatology (2021)
Axial involvement in psoriatic arthritis: An update for rheumatologists
Denis Poddubnyy et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Denis Poddubnyy et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)
Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Joy Feld et al.
RHEUMATOLOGY (2020)
Peripheral spondyloarthritis: a neglected entity-state of the art
Philippe Carron et al.
RMD OPEN (2020)
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naive active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials
Philip S. Helliwell et al.
RMD OPEN (2020)
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
EFFICACY OF IXEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS (PSA) PATIENTS WITH AXIAL PAIN STARTING BEFORE AGE 45: A SUBGROUP ANALYSIS OF SPIRIT-P1 AND SPIRIT-P2 PHASE 3 CLINICAL TRIALS
Atul Deodhar et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Efficacy of ustekinumab in biologic-naive patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2
Iain B. McInnes et al.
RMD OPEN (2019)
Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria
Fabian Proft et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2018)
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study
Philippe Carron et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
Arthur Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors
Ennio Lubrano et al.
JOURNAL OF RHEUMATOLOGY (2016)
Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
Philip Mease et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Disease pattern of spondyloarthropathies in Spain:: description of the first national registry (REGISPONSER) -: extended report
E. Collantes et al.
RHEUMATOLOGY (2007)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)